Gene · 6197
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data. | Expert Opin Ther Targets | 2024 | 39632509 | PubTator, text mining | PubMed |
| p21Waf1/Cip1 Is a Novel Downstream Target of 40S Ribosomal S6 Kinase 2. | Cancers (Basel) | 2024 | 39594738 | PubTator, text mining | PubMed |
| Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays. | Elife | 2024 | 39526730 | PubTator, text mining | PubMed |
| Stimulation of insulin secretion induced by low 4-cresol dose involves the RPS6KA3 signalling pathway. | PLoS One | 2024 | 39446839 | PubTator, text mining | PubMed |
| RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth. | Cell Death Discov | 2024 | 39424777 | PubTator, text mining | PubMed |
| Injectable thermo-responsive Poloxamer hydrogel/methacrylate gelatin microgels stimulates bone regeneration through biomimetic programmed release of SDF-1a and IGF-1. | Int J Biol Macromol | 2024 | 38821297 | PubTator, text mining | PubMed |
| Phosphorylation of caspase-8 by RSKs via organ-constrained effects controls the sensitivity to TNF-induced death. | Cell Death Discov | 2024 | 38789425 | PubTator, text mining | PubMed |
| MiR-29 and MiR-140 regulate TRAIL-induced drug tolerance in lung cancer. | Anim Cells Syst (Seoul) | 2024 | 38693921 | PubTator, text mining | PubMed |
Exploring the therapeutic mechanism of potential phytocompounds from Kalanchoe pinnata in the treatment of diabetes mellitus by integrating network pharmacology, molecular docking and simulation approach. | Saudi Pharm J | 2024 | 38550331 | PubTator, text mining | PubMed |
| Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs. | Pathogens | 2024 | 38392865 | PubTator, text mining | PubMed |
| Identification of RSK substrates using an analog-sensitive kinase approach. | J Biol Chem | 2024 | 38342435 | PubTator, text mining | PubMed |
| MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers. | Eur J Med Res | 2024 | 38281029 | PubTator, text mining | PubMed |
| Genetic Epilepsies and Developmental Epileptic Encephalopathies with Early Onset: A Multicenter Study. | Int J Mol Sci | 2024 | 38279250 | PubTator, text mining | PubMed |
| Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review. | Int J Mol Sci | 2024 | 38255778 | PubTator, text mining | PubMed |
| HSPB8 Facilitates the Oncogenesis and Advancement of Bladder Cancer via Activation of HSP27. | J Cancer | 2024 | 38213722 | PubTator, text mining | PubMed |
| Cellular and molecular mechanisms of highly active mesenchymal stem cells in the treatment of senescence of rhesus monkey ovary. | Stem Cell Res Ther | 2024 | 38191526 | PubTator, text mining | PubMed |
| Establishment and characterization of a highly metastatic hepatocellular carcinoma cell line. | Bioengineered | 2024 | 38184822 | PubTator, text mining | PubMed |
| Unveiling the role of host kinases at different steps of influenza A virus life cycle. | J Virol | 2024 | 38174932 | PubTator, text mining | PubMed |
| Synthesis and anti-tumor activity evaluation of 1H-pyrrolo[2,3-b]pyridine-2-carboxamide derivatives with phenyl sulfonamide groups as potent RSK2 inhibitors. | Chem Biol Drug Des | 2024 | 37852922 | PubTator, text mining | PubMed |
| The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity. | J Cardiovasc Transl Res | 2024 | 37725271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6197/papers?page=4